Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 is Expressed inOsteoblasts and Regulated by PTH

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 607-612

  Sharma, Sonali ^a   Mahalingam, Chandrika D ^a   Das, Varsha ^a   Jamal, Shazia ^a   Levi, Edi ^a   Rishi, Arun K ^a   Datta, Nabanita S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CARP 1; Differentiation; Osteoblast; PTH

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; APOPTOSIS REGULATORY PROTEIN; CELL CYCLE AND APOPTOSIS REGULATORY PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PARATHYROID HORMONE; PMA; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CALVARIA; CARTILAGE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FEMUR; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARP-1; CELL CYCLE AND APOPTOSIS REGULATORY PROTEIN -1; DIFFERENTIATION; EDTA; ERK; ETHYLENEDIAMINE TETRAACETIC ACID; EXTRACELLULAR SIGNAL REGULATED KINASE; MAPK; MAPK KINASE; MC-4; MC3T3-E1 CLONE 4; MEK; MITOGEN-ACTIVATED PROTEIN KINASE; OSTEOBLAST; PARATHYROID HORMONE; PHORBOL-12-MYRISTATE-13 ACETATE; PKA; PKC; PMA; PROTEIN KINASE A; PROTEIN KINASE C; PTH; PTH RECEPTOR-1; PTHR1;

3T3 CELLS; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE PROTEINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; PARATHYROID HORMONE;

MUS;

EID: 84880036137     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.136     Document Type: Article

References (34)

1. Lian J.B., Stein G.S., Aubin J.E. Bone formation: maturation and functional activities of osteoblast lineage cells. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 13-28. American Society for Bone and Mineral Research, Washington. M.J. Favus (Ed.).
2. Hock J.M., Fitzpatrick L.A., Bilezikian J.P. Actions of parathyroid hormone. Principles of Bone Biology 2002, 463-482. Academic Press, San Diego. second ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
3. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., Hodsman A.B., Eriksen E.F., Ish-Shalom S., Genant H.K., Wang O., Mitlak B.H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 2001, 344:1434-1441.
4. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007, 40:1434-1446.
5. Datta N.S., Abou-Samra A.B. PTH and PTHrP signaling in osteoblasts. Cell. Signal. 2009, 21:1245-1254.
6. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 1999, 104:439-446.
7. Wang Y.H., Liu Y., Rowe D.W. Effects of transient PTH on early proliferation, apoptosis, and subsequent differentiation of osteoblast in primary osteoblast cultures. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E594-603.
8. Miller P.D., Bilezikian J.P., Diaz-Curiel M., Chen P., Marin F., Krege J.H., Wong M., Marcus R. Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide. J. Clin. Endocrinol. Metab. 2007, 92:3535-3541.
9. Pietrogrande L. Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis. Int. J. Womens Health 2010, 1:193-203.
10. Jiang Y., Puliyappadamba V.T., Zhang L., Wu W., Wali A., Yaffe M.B., Fontana J.A., Rishi A.K. A novel mechanism of cell growth regulation by cell cycle and apoptosis regulatory protein (CARP)-1. J. Mol. Signal. 2010, 5:7.
11. Rishi A.K., Zhang L., Boyanapalli M., Wali A., Mohammad R.M., Yu Y., Fontana J.A., Hatfield J.S., Dawson M.I., Majumdar A.P., Reichert U. Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. J. Biol. Chem. 2003, 278:33422-33435.
12. Hervy M., Hoffman L.M., Jensen C.C., Smith M., Beckerle M.C. The LIM protein zyxin binds CARP-1 and promotes apoptosis. Genes Cancer 2010, 1:506-515.
13. Puliyappadamba V.T., Wu W., Bevis D., Zhang L., Polin L., Kilkuskie R., Finley R.L., Larsen S.D., Levi E., Miller F.R., Wali A., Rishi A.K. Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. J. Biol. Chem. 2011, 286:38000-38017.
14. Datta N.S., Chen C., Berry J.E., McCauley L.K. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. J. Bone Miner. Res. 2005, 20:1051-1064.
15. Datta N.S., Pettway G.J., Chen C., Koh A.J., McCauley L.K. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells. J. Bone Miner. Res. 2007, 22:951-964.
16. Datta N.S., Kolailat R., Fite A., Pettway G., Abou-Samra A.B. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Cell. Signal. 2010, 22:457-466.
17. Jilka R.L., O'Brien C.A., Ali A.A., Roberson P.K., Weinstein R.S., Manolagas S.C. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009, 44:275-286.
18. Rishi A.K., Zhang L., Yu Y., Jiang Y., Nautiyal J., Wali A., Fontana J.A., Levi E., Majumdar A.P. Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. J. Biol. Chem. 2006, 281:13188-13198.
19. Kim J.H., Yang C.K., Heo K., Roeder R.G., An W., Stallcup M.R. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell 2008, 31:510-519.
20. Mahalingam C.D., Sampathi B.R., Sharma S., Datta T., Das V., Abou-Samra A.B., Datta N.S. MKP1-dependent PTH modulation of bone matrix mineralization in female mice is osteoblast maturation stage specific and involves P-ERK and P-p38 MAPKs. J. Endocrinol. 2013, 216:315-329.
21. Mahalingam C.D., Datta T., Patil R.V., Kreider J., Bonfil R.D., Kirkwood K.L., Goldstein S.A., Abou-Samra A.B., Datta N.S. Mitogen activated protein kinase phosphatase-1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone. J. Endocrinol. 2011, 211:145-156.
22. Ou C.Y., Kim J.H., Yang C.K., Stallcup M.R. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells. J. Biol. Chem. 2009, 284:20629-20637.
23. Rawadi G., Roman-Roman S. Wnt signalling pathway: a new target for the treatment of osteoporosis. Expert Opin. Ther. Targets 2005, 9:1063-1077.
24. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 2006, 116:1202-1209.
25. Baron R., Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007, 148:2635-2643.
26. Almeida M., Han L., Bellido T., Manolagas S.C., Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 2005, 280:41342-41351.
27. Kulkarni N.H., Halladay D.L., Miles R.R., Gilbert L.M., Frolik C.A., Galvin R.J., Martin T.J., Gillespie M.T., Onyia J.E. Effects of parathyroid hormone on Wnt signaling pathway in bone. J. Cell. Biochem. 2005, 95:1178-1190.
28. Tobimatsu T., Kaji H., Sowa H., Naito J., Canaff L., Hendy G.N., Sugimoto T., Chihara K. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 2006, 147:2583-2590.
29. Wan M., Yang C., Li J., Wu X., Yuan H., Ma H., He X., Nie S., Chang C., Cao X. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 2008, 22:2968-2979.
30. Suzuki A., Ozono K., Kubota T., Kondou H., Tachikawa K., Michigami T. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells. J. Cell. Biochem. 2008, 104:304-317.
31. Bonnet N., Conway S.J., Ferrari S.L. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc. Natl. Acad. Sci. USA 2012, 109:15048-15053.
32. Bodine P.V. Wnt signaling control of bone cell apoptosis. Cell Res. 2008, 18:248-253.
33. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000, 19:6778-6791.
34. Anantharaman V., Aravind L. Analysis of DBC1 and its homologs suggests a potential mechanism for regulation of sirtuin domain deacetylases by NAD metabolites. Cell Cycle 2008, 7:1467-1472.